Eli Lilly regulatory update

The FDA's Oncologic Drug Advisory Committee (ODAC) recommended approval of Lilly's Gemzar (gemcitabine hydrochloride), a nucleoside analog, to treat advanced metastatic pancreatic cancer. The Indiana...